[ad_1]
A team of scientists from a biotechnology company in Israel said that they would have a cure for cancer – all cancers – within one year.
Unfortunately, their claims have been slaughtered by scientists.
In recent articles in Israel and the United States, Accelerated Evolution Biotechnologies Ltd., or AEBi, founded in 2000 by the technology incubator ITEK Weizmann, announced that a new treatment being developed by the company offer a complete cure for cancer through "no or minimal side effects at a cost well below most other treatments available on the market. "
The treatment, according to Dan Aridor, chairman of AEBi's board, and Dr. Ilan Morad, chief executive, called MuTaTo or multi-target toxin, works essentially like an anticancer antibiotic, they told the Jerusalem Post. They stated that the results of the preclinical trials were very good.
But other scientists have quickly rejected these claims, calling them "fallacious", "highly irresponsible", "unfounded" and even "cruel".
Skeptical scientists note that the research group has not released any findings to support their claims, as is traditional in the scientific community.
Morad told the Times of Israel earlier this week that he had not published his research in medical journals because he "could not afford" to do so.
But reputable scientific journals, which are peer reviewed and highly respected, do not ask for serious scientific research, although the process can be rigorous.
In Forbes, cancer researcher and cancer survivor Victoria Forster called AEBI in advance with information about their so-called cure.
"To find out more about what the company provides, there are two graphs and images taken under the microscope, far less than what I had provided as part of an undergraduate research project. 39, six weeks ten years ago, "she wrote.
It also calls for a statement that a cure will work for all different types of cancer among more than 200 types, which constitutes a "huge red flag" stating that such an affirmation is "highly unlikely".
In the meantime, she notes, the American Cancer Society has published a blog post from its deputy chief of health explaining why the company's claims are unlikely, including the fact that their approach is not so bad. unique and that other similar approaches have failed.
The CEO of the Israel Advanced Technology Industries group said the whole situation "has damaged the image of Israel's life sciences sector."
Until now, the tests have been conducted only on mice and not on humans, although the scientists told the Jerusalem Post that their results were "consistent and reproducible". The company told the Times of Israel that it was considering advancing its research and achieving better results. clinical trials as quickly as possible.
[ad_2]
Source link
